Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs
N.M.J. Rupniak(Alzheimer's Society), C. D. Marsden(Parkinson's UK), Gavin J. Kilpatrick(Alzheimer's Society), Eamonn Kelly(University of Bristol), Peter Jenner(King's College London), Simon Fleminger(King's College Hospital), M.D. Hall
Cited by 25
Related Papers
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
|British Journal of Pharmacology|2015|603
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
|British Journal of Pharmacology|2017|597
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors
|British Journal of Pharmacology|2017|589